Inventor
Rinse KLOOSTER
Inventor
NL
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
C12NMicroorganisms or enzymes11%
PatentTitleYear
12,577,306Bispecific anti PD1-anti TIM3 antibodies202612,570,747TGF-beta-RII binding proteins202612,325,746Bispecific antibody202512,091,461Bispecific antibody202411,753,470Bispecific anti PD1-anti TIM3 antibodies202311,732,043Antibodies that modulate a biological activity expressed by a cell202311,685,786Binding molecules that bind CD137 and PD-L1202311,667,714Binding molecules that modulate a biological activity expressed by a cell2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to MERUS NV (6)· patent assignee history
2023–2026Based in NL· patent location history
2024–2025Patents assigned to ONO PHARMACEUTICAL CO (2)· patent assignee history
2026Patents assigned to MERUS B V (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERUS NV | 6 | 2023–2026 |
| ONO PHARMACEUTICAL CO | 2 | 2024–2025 |
| MERUS B V | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 8 | 2023–2026 |